Dennis J. Selkoe, MD
For definition of terms used, see Glossary.
Acknowledgments: The author thanks his colleagues and collaborators for many helpful discussions.
Grant Support: By the National Institutes of Health, Alzheimer's Association, and the Foundation for Neurologic Diseases. Dr. Selkoe is a founding scientist of Athena Neurosciences, now Elan Corporation.
Potential Financial Conflicts of Interest:Honoraria and Patents received: Elan Corp.
Requests for Single Reprints: Dennis J. Selkoe, MD, Center for Neurologic Diseases, Brigham and Women's Hospital, 77 Avenue Louis Pasteur, HIM 730, Boston, MA 02115.
Learn more about subscription options.
Register Now for a free account.
Selkoe DJ. Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies. Ann Intern Med. 2004;140:627–638. doi: 10.7326/0003-4819-140-8-200404200-00047
Download citation file:
Published: Ann Intern Med. 2004;140(8):627-638.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only